The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Molecular mechanisms and clinical applications of angiogenesis
Open accessAbstract
Blood vessels deliver oxygen and nutrients to every part of the body, but also nourish diseases such as cancer. Over the past decade, our understanding of the molecular mechanisms of angiogenesis (blood vessel growth) has increased at an explosive rate and has led to the approval of anti-angiogenic drugs for cancer and eye diseases. So far, hundreds of thousands of patients have benefited from blockers of the angiogenic protein vascular endothelial growth factor, but limited efficacy and resistance remain outstanding problems. Recent preclinical and clinical studies have shown new molecular targets and principles, which may provide avenues for improving the therapeutic benefit from anti-angiogenic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In clinical settings, this approach has been proven to be ineffective when used alone [23].”
From Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis (2023) · cites this paper as [23]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition to increasing drug resistance, a high SS could influence tumor cells' gene expression, comprise immune cells ability to kill cancerous cells or even turn macrophages to tumorfriendly cells, thereby enhancing the metastatic potential of cancer cells [180-184].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [184]
Experimental — accuracy not yet measuredIn the citing paper
“This disparity is, in part, attributed to VEGF-independent nonangiogenic mechanisms of vascularization (such as vessel co-option) that are exploited by cancer cells at the early stages of metastasis formation6,9,55,56”
From Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges (2018) · cites this paper as [9]
In the citing paper
“Several cellular and molecular mechanisms of escape from antiangiogenic therapies have been postulated and investigated, including activation of alternative angiogenic pathways, recruitment of proangiogenic myeloid cells, increased pericyte cell coverage of tumour blood vessels, increased tumour cell invasion, and alternative modes of vessel recruitment7,9,80”
From Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges (2018) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 1×
“Tumour vessels become abnormal in almost all aspects of their structure and functio”
BackgroundSelf-citationAngiogenesis in health and disease
Carmeliet, P. (2003) · Nature Medicine · doi:10.1038/nm0603-653 · Cited by 4,379
Self-citationIntegrins in cancer: biological implications and therapeutic opportunities
Desgrosellier, J. S., & Cheresh, D. A. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2748 · Cited by 3,815
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Angiogenesis in life, disease and medicine
Carmeliet, P. (2005) · Nature · doi:10.1038/nature04478 · Cited by 3,551
Self-citationVEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Modes of resistance to anti-angiogenic therapy
Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2442 · Cited by 2,953 · cited 1×
“Aberrant FGF signalling promotes tumour angiogenesis and mediates the escape of tumour vascularization from VEGF- or epidermal growth factor receptor (EGFR)-inhibitor treatmen”
BackgroundMatrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797
Molecular regulation of vessel maturation
Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm0603-685 · Cited by 2,594
Self-citationHypoxia-inducible factors and the response to hypoxic stress
Majmundar, A. J., Wong, W. J., & Simon, M. C. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.022 · Cited by 2,380
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 1,021
Harnoss, J. M., Thomas, A. L., Reichelt, M., Guttman, O., Wu, T. D., Marsters, S. A., Shemorry, A., Lawrence, D. A., Kan, D., Segal, E., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3108 · Cited by 94
Xie, L., Luo, Z., Zhao, Z., & Chen, T. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00917 · Cited by 94
Li, D., Qu, C., Liu, Q., Wu, Y., Hu, X., Qian, K., Chang, B., He, S., Yuan, Y., Li, Y., et al. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201906343 · Cited by 94
Wang, J., Wang, Y., Wang, S., Cai, J., Shi, J., Sui, X. Y., Cao, Y., Huang, W., Chen, X., Cai, Z., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5739 · Cited by 94
Pulmonary vascular changes in asthma and COPD
Harkness, L. M., Kanabar, V., SHARMA, H. S., Westergren‐Thorsson, G., & Larsson‐Callerfelt, A. (2014) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2014.09.003 · Cited by 94
Morphogenesis of 3D vascular networks is regulated by tensile forces
Rosenfeld, D., Landau, S., Shandalov, Y., Raindel, N., Freiman, A., Shor, E., Blinder, Y. J., Vandenburgh, H. H., Mooney, D. J., & Levenberg, S. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522273113 · Cited by 94
Shvartsman, D. E., White, H. S., Lee, K., Kearney, C. J., Brudno, Y., Ho, N., Cezar, C. A., McCann, C. M., Anderson, E., Koullias, J., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.76 · Cited by 93
Valdor, R., García‐Bernal, D., Bueno, C., Rodenas, M., Moraleda, J. M., Macián, F., & Martı́nez, S. (2017) · Oncotarget · doi:10.18632/oncotarget.19804 · Cited by 93
Gieling, R. G., Parker, C. A., Costa, L. A. D., Robertson, N., Harris, A. L., Stratford, I. J., & Williams, K. J. (2012) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2012.736979 · Cited by 92
Angiogenesis: A Target in Solid Tumors, Also in Leukemia?
Schmidt, T., & Carmeliet, P. (2011) · Hematology · doi:10.1182/asheducation-2011.1.1 · Cited by 92
Self-citationXu, R., Li, J., Bai, Y., Xu, J., Liu, T., Shen, L., Wang, L., Pan, H., Cao, J., Zhang, D., et al. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0384-9 · Cited by 92
CD44(+) tumor cells promote early angiogenesis in head and neck squamous cell carcinoma
Ludwig, N., Szczepański, M. J., Głuszko, A., Szafarowski, T., Azambuja, J. H., Dolg, L., Gellrich, N., Kampmann, A., Whiteside, T. L., & Zimmerer, R. M. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.10.010 · Cited by 92
Aging Reprograms the Hematopoietic-Vascular Niche to Impede Regeneration and Promote Fibrosis
Chen, Y., Pu, Q., Ma, Y., Zhang, H., Ye, T., Zhao, C., Huang, X., Ren, Y., Qiao, L., Liu, H., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.11.019 · Cited by 92
Monitoring of cell-cell communication and contact history in mammals
Zhang, S., Zhao, H., Liu, Z., Liu, K., Zhu, H., Pu, W., He, L., Wang, R. A., & Zhou, B. (2022) · Science · doi:10.1126/science.abo5503 · Cited by 92
Anti-vascular therapies in ovarian cancer: moving beyond anti-VEGF approaches
Choi, H. J., Armaiz-Peña, G. N., Pradeep, S., Cho, M. S., Coleman, R. L., & Sood, A. K. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-014-9538-9 · Cited by 92
Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1
Luo, L., Uehara, H., Zhang, X., Das, S. K., Olsen, T., Holt, D. G., Simonis, J. M., Jackman, K., Singh, N., Miya, T. R., et al. (2013) · eLife · doi:10.7554/elife.00324 · Cited by 92
Targeted Drug Delivery Systems Mediated by a Novel Peptide in Breast Cancer Therapy and Imaging
Lu, R., Chen, M., Chang, D.-K., Chiu, C., Lin, W.-C., Yan, S.-L., Wang, Y., Kuo, Y., Yeh, C.-Y., Lo, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066128 · Cited by 92
Fang, Z. H., He, Q., Li, Q., Chen, X., Baral, S., Jin, H., Zhu, Y., Li, M., Xia, Y., Mao, L., et al. (2016) · The FASEB Journal · doi:10.1096/fj.201500126 · Cited by 92
Cascone, T., Xu, L., Lin, H. Y., Liu, W., Tran, H. T., Liu, Y., Howells, K., Haddad, V., Hanrahan, E. O., Nilsson, M. B., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-3216 · Cited by 92
Jumping the barrier: VE‐cadherin, VEGF and other angiogenic modifiers in cancer
Le Guelte, A., Dwyer, J., & Gavard, J. (2011) · Biology of the Cell · doi:10.1042/bc20110069 · Cited by 91
Bakopoulou, A., Κritis, A., Andreadis, D., Papachristou, E., Leyhausen, G., Koidis, P. T., Geurtsen, W., & Tsiftsoglou, A. S. (2015) · Stem Cells and Development · doi:10.1089/scd.2015.0197 · Cited by 91
Sarkar, D., & Fisher, P. B. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-401676-7.00002-4 · Cited by 91
Rac1/Pak1/p38/MMP-2 Axis Regulates Angiogenesis in Ovarian Cancer
González-Villasana, V., Fuentes‐Mattei, E., Ivan, C., Dalton, H. J., Rodriguez‐Aguayo, C., Thomas, R. J. F.-D., Aslan, B., Monroig-Bosque, P. D. C., Velázquez-Torres, G., Previs, R. A., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2279 · Cited by 91
Benn, A., Hiepen, C., Osterland, M., Schütte, C., Zwijsen, A., & Knaus, P. I. (2017) · The FASEB Journal · doi:10.1096/fj.201700193rr · Cited by 91
Shivalingam, C., Purushothaman, B., Balasubramaniam, M., Chandran, R. R., & Balakumar, S. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.110598 · Cited by 91
Lowerison, M. R., Huang, C., Lucien, F., Chen, S., & Song, P. (2020) · Scientific Reports · doi:10.1038/s41598-020-59338-z · Cited by 91
From Neurodevelopmental to Neurodegenerative Disorders: The Vascular Continuum
Ouellette, J., & Lacoste, B. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.749026 · Cited by 91
Du, H., Li, S., Lu, J., Tang, L.-Z., Jiang, X., He, X., Liang, J., Liao, X., Cui, T., Huang, Y., et al. (2023) · Burns & Trauma · doi:10.1093/burnst/tkad020 · Cited by 91
Opitz, R., Maquet, E., Huisken, J., Antonica, F., Trubiroha, A., Pottier, G., Janssens, V., & Costagliola, S. (2012) · Developmental Biology · doi:10.1016/j.ydbio.2012.09.011 · Cited by 91
Reactive Oxygen Species in Vascular Formation and Development
Zhou, Y., Yan, H. M., Guo, M., Zhu, J., Xiao, Q., & Zhang, L. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/374963 · Cited by 91
Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and Inflammation
Rivas-Fuentes, S., Salgado-Aguayo, A. R., Belloso, S. P., Rosete, P. G., Alvarado‐Vásquez, N., & Aquino‐Jarquín, G. (2015) · Journal of Cancer · doi:10.7150/jca.12286 · Cited by 91
Li, W., Kandhare, A. D., Mukherjee-Kandhare, A. A., & Bodhankar, S. L. (2018) · EXCLI journal · doi:10.17179/excli2018-1036 · Cited by 91
van Elmpt, W., Zegers, C. M. L., Reymen, B. J. T., Even, A. J. G., Dingemans, A. C., Öllers, M., Wildberger, J. E., Mottaghy, F. M., Das, M., Troost, E. G. C., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3169-4 · Cited by 90
Dickman, C. T., Lawson, J., Jabalee, J., MacLellan, S. A., LePard, N. E., Bennewith, K. L., & Garnis, C. (2017) · Oncotarget · doi:10.18632/oncotarget.14862 · Cited by 90
Impact of Metabolic Diseases on Cerebral Circulation: Structural and Functional Consequences
Coucha, M. M., Abdelsaid, M. A., Ward, R., Abdul, Y., & Ergul, A. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170019 · Cited by 90
Hydrogel vehicles for sequential delivery of protein drugs to promote vascular regeneration
Zhao, W., Volkova, E., Blatchley, M. R., & Gerecht, S. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.08.005 · Cited by 90
Navigating tumor angiogenesis: therapeutic perspectives and myeloid cell regulation mechanism
Yang, F., Lee, G., & Fan, Y. (2024) · Angiogenesis · doi:10.1007/s10456-024-09913-z · Cited by 90
Adult skull bone marrow is an expanding and resilient haematopoietic reservoir
Koh, B. I., Mohanakrishnan, V., Jeong, H., Park, H., Kruse, K., Choi, Y. J., Nieminen-Kelhä, M., Kumar, R., Pereira, R. S., Adams, S., et al. (2024) · Nature · doi:10.1038/s41586-024-08163-9 · Cited by 90
Ronca, R., Giacomini, A., Rusnati, M., & Presta, M. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1062475 · Cited by 90
Oncogenes in non-small-cell lung cancer: emerging connections and novel therapeutic dynamics
Stella, G. M., Luisetti, M., Pozzi, E., & Comoglio, P. M. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70009-2 · Cited by 90
Zhao, N., Suzuki, A., Zhang, X., Shi, P., Abune, L., Coyne, J., Jia, H., Xiong, N., Zhang, G., & Wang, Y. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b02462 · Cited by 89
Ruiz, S., Zhao, H., Chandakkar, P., Papoin, J., Choi, H., Nomura-Kitabayashi, A., Patel, R., Gillen, M. C., Diao, L., Chatterjee, P. K., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127425 · Cited by 89
Mammalian phospholipase D: Function, and therapeutics
McDermott, M. I., Wang, Y., Wakelam, M. J. O., & Bankaitis, V. A. (2019) · Progress in Lipid Research · doi:10.1016/j.plipres.2019.101018 · Cited by 89
Angiogenesis in gynecological cancers and the options for anti-angiogenesis therapy
Yetkin-Arik, B., Kastelein, A. W., Klaassen, I., Jansen, C. H. J. R., Latul, Y. P., Vittori, M., Bırı, A., Kahraman, K., Griffioen, A. W., Amant, F. C., et al. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188446 · Cited by 89
Wang, D.-P., Liu, K.-L., Li, X., Lu, G., Xue, W.-H., Qian, X.-H., Olounfeh, K. M., & Meng, F. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.113083 · Cited by 89
A highly selective and potent CXCR4 antagonist for hepatocellular carcinoma treatment
Song, J., Chang, C.-C., Wu, C.-H., Dinh, T. K., Jan, J., Huang, K., Chou, M., Shiue, T.-Y., Yeh, K., Ke, Y., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2015433118 · Cited by 89
Current and Future Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration
Kaiser, S., Arepalli, S., & Ehlers, J. P. (2021) · Journal of Experimental Pharmacology · doi:10.2147/jep.s259298 · Cited by 89
Rufaihah, A. J., Vaibavi, S. R., Plotkin, M., Shen, J., Nithya, V., Wang, J., Seliktar, D., & Kofidis, T. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.031 · Cited by 89
Kraan, J., van den Broek, P., Verhoef, C. K., Grünhagen, D. J., Taal, W., Gratama, J. W., & Sleijfer, S. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.286 · Cited by 89
Bizotto, T. S. G., da Cunha, B. R., Raposo, L. S., Maníglia, J. V., Cury, P. M., Rodrigues‐Lisoni, F. C., Tajara, E. H., & Oliani, S. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111317 · Cited by 89
MicroRNA 329 Suppresses Angiogenesis by Targeting CD146
Wang, P., Luo, Y., Duan, H., Xing, S., Zhang, J., Lü, D., Feng, J., Yang, D., Song, L., & Yan, X. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00343-13 · Cited by 89
Jia, L., Zhou, X., Huang, X., Xu, X., Jia, Y., Wu, Y., Yao, J., Wu, Y., & Wang, K. (2018) · The FASEB Journal · doi:10.1096/fj.201701337rr · Cited by 89
Recent advances in anti-angiogenic nanomedicines for cancer therapy
Bhattarai, P., Hameed, S., & Dai, Z. (2018) · Nanoscale · doi:10.1039/c7nr09612g · Cited by 90
Concise Review: The Regenerative Journey of Pericytes Toward Clinical Translation
Cathery, W., Faulkner, A., Maselli, D., & Madeddu, P. R. (2018) · Stem Cells · doi:10.1002/stem.2846 · Cited by 88
Yu, Z., Cai, Y., Deng, M., Li, D., Wang, X., Zheng, H., Xu, Y., Li, W., & Zhang, W. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1014-y · Cited by 88
Hao, D., Fan, Y., Xiao, W., Liu, R., Pivetti, C. D., Walimbe, T., Guo, F., Zhang, X., Farmer, D. L., Wang, F., et al. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.03.005 · Cited by 88
Cerebrovascular disorders: molecular insights and therapeutic opportunities
Storkebaum, E., Quaegebeur, A., Vikkula, M., & Carmeliet, P. (2011) · Nature Neuroscience · doi:10.1038/nn.2947 · Cited by 88
Self-citationEechoute, K., van der Veldt, A. A. M., Oosting, S. F., Kappers, M. H. W., Wessels, J. A. M., Gelderblom, H. A. J., Guchelaar, H., Reyners, A. K. L., van Herpen, C. M. L., Haanen, J. B. A. G., et al. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.136 · Cited by 88
Bougnaud, S., Golebiewska, A., Oudin, A., Keunen, O., Harter, P. N., Mäder, L., Azuaje, F. J., Fritah, S., Stieber, D., Kaoma, T., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7454 · Cited by 88
Durymanov, M. O., Kamaletdinova, T., Lehmann, S. E., & Reineke, J. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.06.013 · Cited by 88
Concise Review: The Endothelial Cell Extracellular Matrix Regulates Tissue Homeostasis and Repair
Witjas, F. M. R., van den Berg, B. M., van den Berg, C. W., Engelse, M. A., & Rabelink, T. J. (2018) · Stem Cells Translational Medicine · doi:10.1002/sctm.18-0155 · Cited by 88
Molecular alterations of cancer cell and tumour microenvironment in metastatic gastric cancer
Li, W., Ng, J. M.-K., Wong, C. C., Ng, E. K. W., & Yu, J. (2018) · Oncogene · doi:10.1038/s41388-018-0341-x · Cited by 87
Antitumor drug delivery in multicellular spheroids by electropermeabilization
Gibot, L., Wasungu, L., Teissié, J., & Rols, M. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.01.021 · Cited by 87
Guo, H., Zhu, Q., Yu, X., Merugu, S. B., Mangukiya, H. B., Smith, N. G., Li, Z. A., Zhang, B., Negi, H., Rong, R., et al. (2017) · Oncogene · doi:10.1038/onc.2017.132 · Cited by 87
Zhou, Z., Zhang, B., Wang, S., Zai, W., Yuan, A., Hu, Y., & Wu, J. (2018) · Small · doi:10.1002/smll.201801694 · Cited by 87
Wu, S., Ou, T., Xing, N., Jiang, L., Wan, S., Wang, C., Zhang, X., Yang, F., Huang, Y. F., & Cai, Z. (2019) · Nature Communications · doi:10.1038/s41467-019-08576-5 · Cited by 87
The Medical Management of Cerebral Edema: Past, Present, and Future Therapies
Halstead, M., & Geocadin, R. G. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00779-4 · Cited by 87
Improving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma
Gong, C., Xie, Y., Wu, Q., Wang, Y., Deng, S., Xiong, D., Liu, L., Xiang, M., Qian, Z., & Wei, Y. (2012) · Nanoscale · doi:10.1039/c2nr31517c · Cited by 87
In vitro and ex vivo retina angiogenesis assays
Rezzola, S., Belleri, M., Gariano, G., Ribatti, D., Costagliola, C., Semeraro, F., & Presta, M. (2013) · Angiogenesis · doi:10.1007/s10456-013-9398-x · Cited by 87
Macrophages and angiogenesis: a role for Wnt signaling
Newman, A. C., & Hughes, C. C. W. (2012) · Vascular Cell · doi:10.1186/2045-824x-4-13 · Cited by 87
Zhou, H. J., Xu, Z., Wang, Z., Zhang, H., Zhuang, Z. W., Simons, M., & Wang, M. (2018) · Nature Communications · doi:10.1038/s41467-018-05812-2 · Cited by 87
RetractedMesoporous silica nanoparticles as a delivery system for improving antiangiogenic therapy
Sun, J., Jiang, Q. L., Zhang, X., Shan, K., Liu, B.-H., Zhao, C., & Yan, B. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s195504 · Cited by 87
Hydrogen Sulfide and Endothelial Dysfunction: Relationship with Nitric Oxide
Altaany, Z., Moccia, F., Munaron, L., Mancardi, D., & Wang, R. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140706142930 · Cited by 86
Platania, C. B. M., Paola, L. D., Leggio, G. M., Romano, G. L., Drago, F., Salomone, S., & Bucolo, C. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00248 · Cited by 86
Zhang, W., Xiong, Z., Wei, T., Li, Q., Tan, Y. C., Li, L., & Feng, X. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0334-2 · Cited by 86
EndoDB: a database of endothelial cell transcriptomics data
Khan, S., Taverna, F., Rohlenová, K., Treps, L., Geldhof, V., de Rooij, L. P. M. H., Sokol, L., Pircher, A., Conradi, L., Kalucka, J. M., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky997 · Cited by 86
Self-citationAchieving systemic delivery of oncolytic viruses
Hill, C., & Carlisle, R. C. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1617269 · Cited by 86
Li, Q., Li, X., Li, X.-Y., Huo, J., Lv, F., & Luo, T. (2020) · American Journal of Roentgenology · doi:10.2214/ajr.19.22688 · Cited by 86
Omorphos, N. P., Gao, C., Tan, S. S., & Sangha, M. S. (2021) · Molecular Biology Reports · doi:10.1007/s11033-020-06108-9 · Cited by 86
Function and mechanism of mesenchymal stem cells in the healing of diabetic foot wounds
Yu, X., Liu, P., Li, Z., & Zhang, Z. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1099310 · Cited by 86
Arnold, T. D., Ferrero, G. M., Qiu, H., Phan, I. T., Akhurst, R. J., Huang, E. J., & Reichardt, L. F. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5648-11.2012 · Cited by 86
Dihydroartemisinin targets VEGFR2 via the NF-κB pathway in endothelial cells to inhibit angiogenesis
Dong, F., Zhou, X., Li, C., Yan, S., Deng, X., Cao, Z., Li, L., Tang, B., Allen, T. D., & Liu, J. (2014) · Cancer Biology & Therapy · doi:10.4161/15384047.2014.955728 · Cited by 86
Adam, M., Berger, C., Feldner, A., Yang, W.-J., Wüstehube‐Lausch, J., Herberich, S. E., Pinder, M., Gesierich, S., Hammes, H., Augustin, H. G., et al. (2013) · Circulation Research · doi:10.1161/circresaha.113.301686 · Cited by 85
Diosmetin inhibits tumor development and block tumor angiogenesis in skin cancer
Choi, J., Lee, D.-H., Park, S., & Seol, J. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109091 · Cited by 85
Regulatory T Cells in Angiogenesis
Lužnik, Z., Anchouche, S., Dana, R., & Yin, J. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000574 · Cited by 85
Zhang, C., Liu, J., Zou, T., Qi, Y., Yi, B., Dissanayaka, W. L., & Zhang, C. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02349-y · Cited by 85
Shi, M., Du, Z. H., Qi, Y., Li, W., Hu, H., Lin, X., Wang, S., Tang, Z., & Zhou, M. (2022) · Theranostics · doi:10.7150/thno.64244 · Cited by 85
NF1 Deletion Generates Multiple Subtypes of Soft-Tissue Sarcoma That Respond to MEK Inhibition
Dodd, R. D., Mito, J. K., Eward, W. C., Chitalia, R., Sachdeva, M., Ma, Y., Barretina, J., Dodd, L. G., & Kirsch, D. G. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0189 · Cited by 85
CTGF promotes osteosarcoma angiogenesis by regulating miR-543/angiopoietin 2 signaling
Wang, L., Tsai, H., Cheng, Y., Lin, C., Huang, Y., Tsai, C., Xu, G.-H., Wang, S., Fong, Y., & Tang, C. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.01.013 · Cited by 88
Microvesicles in Atherosclerosis and Angiogenesis: From Bench to Bedside and Reverse
Badimón, L., Suades, R., Arderiu, G., Peña, E., Chiva‐Blanch, G., & Padró, T. (2017) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00077 · Cited by 85
Lee, S., Valmikinathan, C. M., Byun, J., Kim, S., Lee, G., Mokarram, N., Pai, S. B., Um, E., Bellamkonda, R. V., & Yoon, Y. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.06.009 · Cited by 85
Tan, Z., Chen, K., Wu, W., Zhou, Y., Zhu, J., Wu, G., Cao, L., Zhang, X., Guan, H., Yang, Y., et al. (2018) · Theranostics · doi:10.7150/thno.27310 · Cited by 84
Tumino, N., Martini, S., Munari, E., Scordamaglia, F., Besi, F., Mariotti, F. R., Bogina, G. S., Mingari, M. C., Vacca, P., & Moretta, L. (2019) · International Journal of Cancer · doi:10.1002/ijc.32262 · Cited by 84
Key components of engineering vascularized 3-dimensional bioprinted bone constructs
Shahabipour, F., Ashammakhi, N. A., Oskuee, R. K., Bonakdar, S., Hoffman, T., Shokrgozar, M. A., & Khademhosseini, A. (2019) · Translational research · doi:10.1016/j.trsl.2019.08.010 · Cited by 84
Circulating Metabolites Originating from Gut Microbiota Control Endothelial Cell Function
Amedei, A., & Morbidelli, L. (2019) · Molecules · doi:10.3390/molecules24213992 · Cited by 84
Mühleder, S., Fernández-Chacón, M., García-Gónzalez, I., & Benedito, R. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03664-y · Cited by 84
Tumor Vaccines: Unleashing the Power of the Immune System to Fight Cancer
Liu, D., Che, X., Wang, X., Ma, C., & Wu, G. (2023) · Pharmaceuticals · doi:10.3390/ph16101384 · Cited by 84
Vascular senescence and aging: mechanisms, clinical implications, and therapeutic prospects
Picos, A., Seoane, N., Campos‐Toimil, M., & Viña, D. (2025) · Biogerontology · doi:10.1007/s10522-025-10256-5 · Cited by 84
Physicochemical regulation of endothelial sprouting in a 3D microfluidic angiogenesis model
Verbridge, S. S., Chakrabarti, A., DelNero, P. F., Kwee, B. J., Varner, J. D., Stroock, A. D., & Fischbach, C. (2013) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.34587 · Cited by 84
Dima, S., Tănase, C., Albulescu, R., Herlea, V., Chivu‐Economescu, M., Purnichescu‐Purtan, R., Dumitraşcu, T., Duda, D. G., & Popescu, I. (2012) · Pancreas · doi:10.1097/mpa.0b013e3182546e13 · Cited by 84
Metadata
- Authors
- Carmeliet, P., & Jain, R. K.
- Affiliations
- Harvard University (US)
- Corresponding author
- Carmeliet, Peter
- Jain, Rakesh K.
- ORCID
- Carmeliet, Peter
- Venue
- Nature
- Published
- 2011-05
- Volume
- 473
- Issue
- 7347
- Pages
- 298-307
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4049445
- OpenAlex
- W1992112921
- Semantic Scholar
- cc1723f25e863386b91340ea03cd76a22de359ae
- Cited by
- 5,467
- References
- 100
- Citations by year
- 2026: 238 · 2025: 316 · 2024: 308 · 2023: 364 · 2022: 393 · 2021: 442 · 2020: 399 · 2019: 399 · 2018: 384 · 2017: 454 · 2016: 369 · 2015: 375 · 2014: 326 · 2013: 342 · 2012: 284
- FWCI
- 29.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (R01CA115767, R01CA085140, P01CA080124, R01CA126642, R01CA163815)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Health Sciences › Medicine › Oncology › Vascular Tumors and Angiosarcomas
- Keywords
- angiogenesis, angiogenesis inhibitors, vascular endothelial growth factor, VEGF inhibitors, drug resistance, molecular targets, cancer, eye diseases, blood vessel development
- MeSH terms
- Animals, Blood Vessels, Fibroblast Growth Factors, Humans, Platelet-Derived Growth Factor, Transforming Growth Factor beta, Neovascularization, Physiologic, Angiogenesis Inhibitors, Vesicular Transport Proteins, Vascular Endothelial Growth Factor A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
